Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Coralie Reger de Moura"'
Autor:
Julie Delyon, Anaïs Vallet, Mélanie Bernard-Cacciarella, Isabelle Kuzniak, Coralie Reger de Moura, Baptiste Louveau, Fanélie Jouenne, Samia Mourah, Céleste Lebbé, Nicolas Dumaz
Publikováno v:
Cancers, Vol 15, Iss 11, p 2888 (2023)
Because BRAF-mutated melanomas are addicted to the Mitogen Activated Protein Kinase (MAPK) pathway they show a high response rate to BRAF and MEK inhibitors. However, the clinical responses to these inhibitors are often short-lived with the rapid ons
Externí odkaz:
https://doaj.org/article/9fa529c6951d44579b7cafcac78fb957
Autor:
Coralie Reger de Moura, Alexandra Landras, Farah Khayati, Uwe Maskos, Kamel Maouche, Maxime Battistella, Suzanne Menashi, Céleste Lebbé, Samia Mourah
Publikováno v:
Cancers, Vol 13, Iss 19, p 4859 (2021)
Malignant melanoma is one of the most aggressive skin cancers and is characterized by early lymph node metastasis and the capacity to develop resistance to therapies. Hence, understanding the regulation of lymphangiogenesis through mechanisms contrib
Externí odkaz:
https://doaj.org/article/35022fab91a54a0c89342144998d6071
Autor:
Pauline Tétu, Julie Delyon, Jocelyne André, Coralie Reger de Moura, Malak Sabbah, Ghanem E Ghanem, Maxime Battistella, Samia Mourah, Céleste Lebbé, Nicolas Dumaz
Publikováno v:
Cancers, Vol 12, Iss 5, p 1062 (2020)
KIT is a bona fide oncogene in a subset of melanoma and, ex vivo, KIT inhibitors are very efficient at killing KIT-mutant melanoma cell lines. However, KIT-mutant melanoma tumors tend to show a de novo resistance in most cases and a limited duration
Externí odkaz:
https://doaj.org/article/5bd985c089ae4443aeeec7255d17093a
Autor:
Alexandra Landras, Coralie Reger de Moura, Fanelie Jouenne, Celeste Lebbe, Suzanne Menashi, Samia Mourah
Publikováno v:
Cancers, Vol 11, Iss 11, p 1803 (2019)
Microenvironment plays a crucial role in tumor development and progression. Cancer cells modulate the tumor microenvironment, which also contribute to resistance to therapy. Identifying biomarkers involved in tumorigenesis and cancer progression repr
Externí odkaz:
https://doaj.org/article/c62fe0d34b6442acb2de128271a7af95
Autor:
Baptiste Louveau, Fanelie Jouenne, Coralie Reger de Moura, Aurelie Sadoux, Barouyr Baroudjian, Julie Delyon, Florian Herms, Adele De Masson, Laetitia Da Meda, Maxime Battistella, Nicolas Dumaz, Celeste Lebbe, Samia Mourah
Publikováno v:
Cancers, Vol 11, Iss 8, p 1203 (2019)
In BRAFV600mut metastatic melanoma, the combination of BRAF and MEK inhibitors (BRAFi, MEKi) has undergone multiple resistance mechanisms, limiting its clinical benefit and resulting in the need for response predicting biomarkers. Based on phase III
Externí odkaz:
https://doaj.org/article/19a0c4c71b7f463794e13b2a99593c1e
Autor:
Coralie Reger de Moura, Laetitia Da Meda, Adèle de Masson, F. Herms, Samia Mourah, Nicolas Dumaz, Céleste Lebbé, Maxime Battistella, Baptiste Louveau, Julie Delyon, Fanélie Jouenne, Aurélie Sadoux, Barouyr Baroudjian
Publikováno v:
Cancers
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1203 (2019)
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1203 (2019)
In BRAFV600mut metastatic melanoma, the combination of BRAF and MEK inhibitors (BRAFi, MEKi) has undergone multiple resistance mechanisms, limiting its clinical benefit and resulting in the need for response predicting biomarkers. Based on phase III